General Information of the Compound
| Compound ID |
CP0510576
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(2-furyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-(2-furyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine
2-(2-furyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-ylamine
856171-18-1
BDBM50232155
CHEMBL399529
SCHEMBL1489577
SSPIGFDAVQVRCH-UHFFFAOYSA-N
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H9N5O
|
||||||||||||||||||
| Molecular Weight |
227.227
|
||||||||||||||||||
| Canonical SMILES |
Nc1cc(nc(n1)-c1ccco1)-n1cccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H9N5O/c12-9-7-10(16-5-2-4-13-16)15-11(14-9)8-3-1-6-17-8/h1-7H,(H2,12,14,15)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SSPIGFDAVQVRCH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Clinical Information about the Compound